Ready-to-use preformed antibiotic loaded spacers for hip, knee and shoulder revisions Choice of Charnley and Müller hip spacer designs, and left and right geometries for each knee Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces the launch […]

(TSX:BCT),(NASDAQ:BCTX),(NASDAQ:BCTXW),(NASDAQ:BCTXZ), Collaboration with MSK's Therapeutics Accelerator Program includes manufacturing, IND and clinical development support of the Bria-OTS+(TM) platform, which includes Bria-BRES+(TM) for breast cancer PHILADELPHIA and VANCOUVER, British Columbia, Oct. 21, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company“), a clinical-stage biotechnology company that develops novel

(NASDAQ:WRAP), MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in innovative public safety and unmanned systems technology, today announced the formation of Wrap Federal, LLC (“Wrap Federal”) a wholly owned subsidiary of the Company dedicated to supporting U.S. federal government clients in the Department

(NASDAQ:ZENA),(Boerse Frankfurt – Freiverkehr:49Q),(BMV:ZENA), VANCOUVER, British Columbia, Oct. 21, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces it has signed an offer to acquire a Southern

(CNSX:URM),(CNSX:URM.CN),(Boerse Frankfurt – Freiverkehr:IOR),(Pinksheets:FAUMF),(PinkSheets:FAUMF), Vancouver, BC, Oct. 21, 2025 (GLOBE NEWSWIRE) — First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (“First American”, or the “Company”) is pleased to announce the appointments of the Hon. Kerry-Lynne D. Findlay and Joseph A. Carrabba to the Board of Directors of the Company (the “Board“). Ms. Findlay

(NasdaqGM:SDST),(NasdaqGM:SDSTW), GREENWICH, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) — Stardust Power Inc. (NASDAQ: SDST) (“Stardust Power” or the “Company”), an American developer of battery-grade lithium carbonate, announced today that it has executed a Letter of Intent (the “Agreement”) with Prairie Lithium for the supply of 6,000 metric tons per annum of lithium carbonate equivalent (“LCE”)

(TSX-V:ECR),(Boerse Frankfurt – Freiverkehr:6CA), VAL-D'OR, Quebec, Oct. 21, 2025 (GLOBE NEWSWIRE) — Cartier Resources Inc. (” Cartier ” or the ” Company “) (TSXV: ECR; FSE: 6CA) is pleased to announce the third batch of results from the fully funded 100,000-m drilling program (2 drill rigs) for the Contact Sector and more precisely, the North

(NASDAQ:PSTV), Expands commercial readiness and diagnostic, manufacturing footprint Appoints new leadership in commercial strategy and technical operations HOUSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announces continued operational execution and commercial progress

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tvardi Therapeutics, Inc. ("Tvardi Therapeutics, Inc.") (NASDAQ:TVRD) concerning possible violations of federal securities laws. On October 13, 2025, Tvardi reported

Vertero Unveils New Strategic Direction Focused on Breaking Barriers in Neurodegenerative Diseases GlobeNewswire October 21, 2025 Formerly Axial Therapeutics, Vertero is rapidly advancing a novel approach to address peripheral drivers of challenging neurodegenerative diseases Lead candidate VT-5006 is a first-in-class small molecule designed to precisely engage a validated target in the GI wall to slow